WhatsApp-Image-2026-04-11-at-7.18.28-AM (52) (8) (10)

TRYLAX® Oral Suspension

TRYLAX® Oral Suspension
Generic Name:
Liquid Paraffin + Magnesium Hydroxide (Milk of Magnesia) + Sodium Picosulfate
Therapeutic Group:
Gastrointestinal Therapy / Laxative Combination
Drug Category:
Stool Softener + Osmotic Laxative + Stimulant Laxative
Content / Composition:
Each 5 ml contains:
* Liquid Paraffin …… 1.25 ml
* Magnesium Hydroxide (Milk of Magnesia) …… 3.75 ml
* Sodium Picosulfate …… 3.33 mg (or equivalent as per formulation)
Available pack: 120 ml oral suspension
Indications:
Indicated for the relief of constipation, including:
* Occasional and chronic constipation
* Hard stools and difficulty in bowel movement
* Bowel regulation in elderly patients
* Pre- and post-operative bowel management
* Constipation associated with hemorrhoids
Dosage:
Adults:
10–15 ml at bedtime or as directed by physician
Children:
5–10 ml (depending on age and physician advice)
(Dose should be adjusted according to response)
Contraindications:
* Hypersensitivity to any component
* Intestinal obstruction or acute abdomen
* Severe dehydration
* Appendicitis or undiagnosed abdominal pain
Administration:
For oral use.
Shake well before use.
Take preferably at bedtime with water.
Ensure adequate fluid intake.
Interaction:
Use caution with:
* Other laxatives (may cause excessive bowel activity)
* Antibiotics (may alter intestinal flora)
* Diuretics (risk of electrolyte imbalance)
* Drugs dependent on electrolyte balance
Compatibility:
Compatible with dietary fiber therapy and hydration measures.
Avoid unnecessary combination with multiple laxatives.
Stability / Storage:
Store below 25°C.
Protect from direct sunlight.
Do not freeze.
Keep bottle tightly closed.
Precautions:
* Avoid prolonged use (risk of dependence)
* Monitor electrolytes in long-term use
* Use cautiously in elderly and debilitated patients
* Pregnancy & lactation: use only if prescribed
* Not recommended for daily long-term use without supervision
Side Effects:
Common:
* Abdominal cramps
* Diarrhea
* Nausea
Others:
* Bloating
* Flatulence
Rare:
* Electrolyte imbalance
* Dehydration (with excessive use)
Website Note:
Triple-action laxative for effective and predictable relief of constipation.
Use under medical supervision for prolonged treatment.

WhatsApp-Image-2026-04-11-at-7.18.28-AM (52) (8) (9)

SBFLOX-MZ® Oral Suspension

SBFLOX-MZ® Oral Suspension
Generic Name:
Ofloxacin + Metronidazole + Simethicone
Therapeutic Group:
Anti-infective / Gastrointestinal Therapy
Drug Category:
Fluoroquinolone Antibiotic + Nitroimidazole Antiprotozoal/Antibacterial + Antiflatulent
Content / Composition:
Each 5 ml contains:
* Ofloxacin …… 50 mg
* Metronidazole …… 120 mg
* Simethicone …… 10 mg
Available pack: 60 ml oral suspension
Indications:
Indicated for the treatment of mixed bacterial and protozoal gastrointestinal infections, including:
* Acute infectious diarrhea
* Dysentery (amoebic & bacterial)
* Gastroenteritis
* Abdominal infections with gas and bloating
* Traveler’s diarrhea
* Mixed infections of GI tract
Dosage:
As directed by physician.
Typical guidance:
* Children: حسب وزن (weight-based dosing)
* Adults: 5–10 ml, 2–3 times daily
(Dose should be individualized based on severity and age)
Contraindications:
* Hypersensitivity to ofloxacin, metronidazole, or any component
* History of quinolone-associated tendon disorders
* CNS disorders (e.g., epilepsy)
* First trimester of pregnancy
* Severe hepatic impairment
Administration:
For oral use.
Shake well before use.
Take after meals with a full glass of water.
Complete full course as prescribed.
Interaction:
Use caution with:
* Alcohol (contraindicated with metronidazole – causes severe reaction)
* Anticoagulants (↑ bleeding risk)
* Antacids & iron (↓ absorption of ofloxacin)
* CNS-active drugs
* QT-prolonging drugs
Compatibility:
Compatible with supportive therapy such as ORS (Oral Rehydration Solution).
Avoid combining with other antibiotics unless prescribed.
Stability / Storage:
Store below 25°C.
Protect from light.
Do not freeze.
Keep bottle tightly closed.
Precautions:
* Ensure adequate hydration during diarrhea
* Avoid alcohol during treatment and at least 48–72 hours after completion
* Use cautiously in children and elderly
* Monitor for CNS effects (dizziness, seizures – rare)
* Not recommended for unnecessary antibiotic use (avoid resistance)
* Pregnancy & lactation: use only if prescribed
Side Effects:
Common:
* Nausea
* Diarrhea
* Abdominal discomfort
* Metallic taste
Others:
* Dizziness
* Headache
* Flatulence
Rare but serious:
* Tendon inflammation/rupture (fluoroquinolones)
* Peripheral neuropathy
* Severe allergic reactions
Website Note:
Broad-spectrum combination for gastrointestinal infections.
Use under medical supervision.
Ensure full course completion to prevent resistance.

WhatsApp-Image-2026-04-11-at-7.18.28-AM (52) (8) (8)

SBOFER-FCM® Injection

SBOFER-FCM® Injection
Generic Name:
Ferric Carboxymaltose
Therapeutic Group:
Haematology / Iron Replacement Therapy
Drug Category:
Parenteral Iron Preparation
Content / Composition:
Each ml contains:
Ferric Carboxymaltose equivalent to elemental iron …… 50 mg
(Available in single-dose vial as per pack)
Indications:
Indicated for the treatment of iron deficiency and iron deficiency anemia, particularly when:
* Oral iron therapy is ineffective or not tolerated
* Rapid iron replenishment is required
* Chronic kidney disease (CKD)
* Postpartum anemia
* Chronic blood loss
* Inflammatory bowel disease (IBD)-associated anemia
Dosage:
As directed by physician.
General guidance:
* Dose based on body weight and iron deficit
* Maximum single dose typically up to 1000 mg iron per week
* Administered as IV injection or infusion
Contraindications:
* Hypersensitivity to ferric carboxymaltose or any component
* Iron overload disorders (e.g., hemochromatosis)
* Non–iron deficiency anemia
* First trimester of pregnancy
Administration:
* For intravenous use only
* Administer by slow IV injection or infusion
* Must be given under medical supervision
* Emergency support should be available during administration
Interaction:
* Avoid concurrent use with oral iron (reduces absorption)
* Caution with other parenteral iron products
* No significant CYP-related drug interactions reported
Compatibility:
Do not mix with other medicinal products except normal saline (if required for infusion).
Administer separately under controlled conditions.
Stability / Storage:
Store below 25°C.
Do not freeze.
Protect from light.
Keep in original packaging.
Precautions:
* Monitor for hypersensitivity reactions during and after administration
* Risk of hypotension during infusion
* Monitor ferritin and transferrin saturation levels
* Use cautiously in liver disorders
* Pregnancy (2nd & 3rd trimester): only if clearly needed
Side Effects:
Common:
* Nausea
* Injection site reactions
* Headache
* Dizziness
Others:
* Hypertension or hypotension
* Flushing
Rare but serious:
* Hypersensitivity reactions (including anaphylaxis)
* Hypophosphatemia
* Severe allergic reactions
Website Note:
High-efficacy intravenous iron therapy.
For hospital and clinical use only.
Administered under strict medical supervision.

WhatsApp-Image-2026-04-11-at-7.18.28-AM (52) (8) (7)

DUPHAST-H® 10 mg Tablets

DUPHAST-H® 10 mg Tablets
Generic Name:
Dydrogesterone
Therapeutic Group:
Gynecology / Hormonal Therapy
Drug Category:
Synthetic Progestogen (Progesterone Analog)
Content / Composition:
Each film-coated tablet contains:
Dydrogesterone …… 10 mg
Indications:
Indicated for the treatment of progesterone deficiency and related gynecological conditions, including:
* Threatened miscarriage
* Recurrent miscarriage due to progesterone deficiency
* Luteal phase deficiency (infertility)
* Dysmenorrhea (painful menstruation)
* Irregular menstrual cycles
* Endometriosis
* Dysfunctional uterine bleeding
* Hormone replacement therapy (HRT) support
Dosage:
As directed by physician.
General guidance:
* Luteal support: 10 mg once or twice daily
* Threatened miscarriage: higher initial dose followed by maintenance
* Menstrual disorders: cyclic dosing depending on indication
(Dosage varies based on condition and clinical response)
Contraindications:
* Hypersensitivity to dydrogesterone or any component
* Undiagnosed vaginal bleeding
* Severe liver disorders
* Known or suspected hormone-dependent malignancies
Administration:
For oral use.
Swallow tablet with water.
May be taken with or without food.
Take regularly at the same time each day.
Interaction:
Use caution with:
* Enzyme-inducing drugs (e.g., rifampicin, phenytoin) – may reduce effectiveness
* Hormonal therapies (monitor balance)
Compatibility:
Compatible with most gynecological and fertility treatments under medical supervision.
Stability / Storage:
Store below 25°C.
Protect from light and moisture.
Keep out of reach of children.
Precautions:
* Monitor patients with history of depression
* Use cautiously in liver disease
* Evaluate abnormal bleeding before initiation
* Pregnancy: commonly used for support under supervision
* Lactation: consult physician before use
Side Effects:
Common:
* Headache
* Nausea
* Breast tenderness
Others:
* Mood changes
* Abdominal discomfort
Rare but serious:
* Liver function disturbances
* Allergic reactions
* Abnormal uterine bleeding
Website Note:
For professional use only.
Hormonal therapy should be used strictly under medical supervision.

WhatsApp-Image-2026-04-11-at-7.18.28-AM (52) (8) (6)

DON-35-H® Tablets

DON-35-H® Tablets
Generic Name:
Cyproterone Acetate + Ethinylestradiol
Therapeutic Group:
Gynecology / Hormonal Therapy
Drug Category:
Anti-androgen + Combined Oral Contraceptive (Estrogen + Progestogen)
Content / Composition:
Each film-coated tablet contains:
* Cyproterone Acetate …… 2 mg
* Ethinylestradiol …… 35 mcg
Indications:
Indicated for hormonal and androgen-related conditions in women, including:
* Hormonal contraception
* Acne (moderate to severe) related to androgen sensitivity
* Hirsutism (excess facial/body hair)
* Polycystic Ovary Syndrome (PCOS)
* Regulation of menstrual cycles
* Seborrhea
Dosage:
Adults (women of reproductive age):
* One tablet daily for 21 consecutive days, followed by 7 days break
* Start next pack after the 7-day interval
* Take at the same time each day
Contraindications:
* Pregnancy or suspected pregnancy
* History of thromboembolic disorders (DVT, PE)
* Severe liver disease
* Hormone-dependent malignancies (e.g., breast cancer)
* Uncontrolled hypertension
* Undiagnosed vaginal bleeding
* Smoking in women over 35 years (relative/strong caution)
Administration:
For oral use.
Swallow with water.
Take regularly at the same time each day for maximum effectiveness.
Interaction:
Use caution with:
* Enzyme-inducing drugs (rifampicin, phenytoin, carbamazepine) – reduce effectiveness
* Antibiotics (may affect hormonal levels)
* Anticoagulants
* Herbal products like St. John’s Wort
Compatibility:
Compatible with gynecological treatments under medical supervision.
Additional contraceptive precautions may be needed when used with interacting drugs.
Stability / Storage:
Store below 25°C.
Protect from light and moisture.
Keep out of reach of children.
Precautions:
* Increased risk of thromboembolism (especially in smokers)
* Monitor blood pressure regularly
* Use cautiously in diabetic patients
* Discontinue if signs of thrombosis appear
* Not recommended during pregnancy
* Requires medical evaluation before initiation
Side Effects:
Common:
* Nausea
* Breast tenderness
* Headache
* Weight changes
Others:
* Mood changes
* Spotting or breakthrough bleeding
* Reduced libido
Rare but serious:
* Thromboembolic events
* Liver dysfunction
* Severe allergic reactions
Website Note:
Hormonal contraceptive and anti-androgen therapy.
Use strictly under medical supervision.
Not suitable for self-medication.

WhatsApp-Image-2026-04-11-at-7.18.28-AM (52) (8) (5)

PROGLAY-H® Tablets

PROGLAY-H® Tablets
Generic Name:
Estradiol Valerate + Norgestrel
Therapeutic Group:
Gynecology / Endocrinology
Drug Category:
Hormone Replacement Therapy (HRT) – Estrogen + Progestogen Combination
Content / Composition:
Each tablet contains:
* Estradiol Valerate …… 2 mg
* Norgestrel …… 0.5 mg
Indications:
Indicated for hormone-related conditions in women, including:
* Hormone Replacement Therapy (HRT) in menopause
* Relief of menopausal symptoms (hot flashes, night sweats, vaginal dryness)
* Prevention of postmenopausal osteoporosis
* Hormonal imbalance management
* Secondary amenorrhea (as per physician advice)
Dosage:
As directed by the physician.
Typical regimen:
* One tablet daily, preferably at the same time each day
* Cyclic or continuous regimen depending on clinical need
Contraindications:
* Known or suspected pregnancy
* History of breast cancer or estrogen-dependent tumors
* Undiagnosed vaginal bleeding
* Active or history of thromboembolic disorders
* Severe hepatic impairment
* Hypersensitivity to any component
Administration:
For oral use.
Swallow with water, with or without food.
Take regularly at the same time each day.
Interaction:
Use caution with:
* Enzyme-inducing drugs (rifampicin, carbamazepine, phenytoin)
* Anticoagulants
* Thyroid medications
* Herbal supplements (e.g., St. John’s Wort)
Compatibility:
Compatible with most HRT regimens under medical supervision.
Clinical monitoring recommended when combined with other hormonal therapies.
Stability / Storage:
Store below 25°C.
Protect from moisture and direct light.
Keep out of reach of children.
Precautions:
* Risk of thromboembolism (DVT, PE)
* Regular breast and pelvic examination recommended
* Monitor blood pressure
* Use lowest effective dose for shortest duration
* Caution in patients with diabetes, cardiovascular disease
* Discontinue if signs of thrombosis or liver dysfunction appear
Side Effects:
Common:
* Nausea
* Breast tenderness
* Headache
* Mood changes
Others:
* Weight changes
* Breakthrough bleeding or spotting
* Edema
Rare but serious:
* Thromboembolic events
* Stroke or myocardial infarction
* Hepatic dysfunction
Website Note (Professional):
Hormone Replacement Therapy should be initiated and monitored by a qualified healthcare professional.
Benefit-risk assessment is required before starting treatment.

WhatsApp-Image-2026-04-11-at-7.18.28-AM (52) (8) (4)

PRIMONUS® Tablets

PRIMONUS® Tablets
Generic Name:
Norethisterone
Therapeutic Group:
Gynecology / Endocrinology
Drug Category:
Progestogen (Synthetic Progesterone)
Content / Composition:
Each tablet contains:
* Norethisterone …… 5 mg
Indications:
Indicated for the management of menstrual and hormonal disorders, including:
* Dysfunctional uterine bleeding (DUB)
* Menorrhagia (heavy menstrual bleeding)
* Irregular menstrual cycles
* Secondary amenorrhea
* Endometriosis
* Premenstrual syndrome (PMS)
* Delay of menstruation (under medical supervision)
Dosage:
As directed by the physician.
Typical regimens:
* Menstrual disorders: 5 mg, 2–3 times daily for 5–10 days
* Delay of menstruation: Start 3 days before expected period, continue as prescribed
* Endometriosis: Continuous dosing as per clinical guidance
Contraindications:
* Known or suspected pregnancy
* Active thromboembolic disorders
* Severe liver disease
* Hormone-dependent malignancies (e.g., breast cancer)
* Undiagnosed vaginal bleeding
* Hypersensitivity to norethisterone
Administration:
For oral use.
Take with water, with or without food.
Maintain regular dosing schedule for optimal effect.
Interaction:
Use caution with:
* Enzyme-inducing drugs (rifampicin, phenytoin, carbamazepine)
* Anticoagulants
* Antidiabetic drugs
* Herbal products (e.g., St. John’s Wort)
Compatibility:
Can be used with other hormonal therapies under medical supervision.
Monitoring required when combined with estrogen-containing therapies.
Stability / Storage:
Store below 25°C.
Protect from light and moisture.
Keep out of reach of children.
Precautions:
* Monitor for risk of thrombosis
* Use with caution in cardiovascular disease
* Monitor liver function in long-term use
* Caution in diabetic patients
* Not recommended during pregnancy
* Evaluate abnormal bleeding before treatment
Side Effects:
Common:
* Nausea
* Headache
* Breast tenderness
* Mood changes
Others:
* Weight gain
* Fluid retention
* Irregular bleeding or spotting
Rare but serious:
* Thromboembolic events
* Hepatic dysfunction
* Visual disturbances
Website Note (Professional):
This medicine should be used only under medical supervision.
Individual risk-benefit assessment is essential before initiating therapy.

WhatsApp-Image-2026-04-11-at-7.18.28-AM (52) (8) (3)

SBDOXIL® Tablets

SBDOXIL® Tablets
Generic Name:
Doxylamine Succinate + Pyridoxine Hydrochloride + Folic Acid
Therapeutic Group:
Gynecology / Obstetrics
Drug Category:
Antiemetic in Pregnancy (Antihistamine + Vitamin B6 + Folic Acid Combination)
Content / Composition:
Each tablet contains:
* Doxylamine Succinate …… 10 mg
* Pyridoxine Hydrochloride (Vitamin B6) …… 10 mg
* Folic Acid …… 2.5 mg
Indications:
Indicated for the management of nausea and vomiting in pregnancy, including:
* Nausea and vomiting of pregnancy (NVP)
* Morning sickness
* Prevention of pregnancy-related nutritional deficiency (Folic Acid support)
* Adjunct therapy in hyperemesis gravidarum (under medical supervision)
Dosage:
As directed by the physician.
Typical regimen:
* Initial: 1–2 tablets at bedtime
* If symptoms persist: additional dose in the morning
* Maximum: as prescribed by physician
Contraindications:
* Hypersensitivity to doxylamine, pyridoxine, or any component
* Concurrent use with MAO inhibitors
* Severe hepatic impairment
* Narrow-angle glaucoma
* Prostatic hypertrophy with urinary retention
Administration:
For oral use.
Take preferably on an empty stomach or as directed.
Swallow whole with water; do not crush or chew (if modified-release).
Interaction:
Use caution with:
* CNS depressants (alcohol, sedatives, benzodiazepines)
* Anticholinergic drugs
* MAO inhibitors
* Other antihistamines
Compatibility:
Compatible with prenatal supplementation regimens.
May be safely combined with iron and calcium supplements under supervision.
Stability / Storage:
Store below 25°C.
Protect from light and moisture.
Keep out of reach of children.
Precautions:
* May cause drowsiness – avoid driving or operating machinery
* Use cautiously in asthma or respiratory conditions
* Monitor in patients with liver impairment
* Use only under medical supervision during pregnancy
* Evaluate severe or persistent vomiting clinically
Side Effects:
Common:
* Drowsiness
* Dry mouth
* Dizziness
Others:
* Constipation
* Blurred vision
* Fatigue
Rare but serious:
* Allergic reactions
* Confusion (high doses)
Website Note (Professional):
This medicine is specifically designed for use during pregnancy and should be taken only under medical supervision.
Clinical evaluation is recommended for persistent or severe symptoms.

WhatsApp-Image-2026-04-11-at-7.18.28-AM (52) (8) (2)

FERTOVIA-H® Capsules

FERTOVIA-H® Capsules
Generic Name:
Myo-Inositol + D-Chiro Inositol + Coenzyme Q10 + Alpha Lipoic Acid + L-Carnitine + Omega-3 Fatty Acids + N-Acetylcysteine (NAC) + Micronutrients
Therapeutic Group:
Gynecology / Reproductive Health / Fertility Support
Drug Category:
Nutraceutical Fertility Supplement (Advanced Female Fertility Complex)
Content / Composition:
Each capsule (or daily dose) contains a scientifically balanced combination of:
* Myo-Inositol …… 4000 mg (per daily dose)
* D-Chiro Inositol
* Coenzyme Q10 (CoQ10)
* Alpha Lipoic Acid
* L-Carnitine
* Omega-3 Fatty Acids (EPA & DHA)
* N-Acetylcysteine (NAC) …… 600 mg
* Essential vitamins & minerals (including Magnesium, Iodine, Choline)
Indications:
Indicated for female fertility support and reproductive health, including:
* Female infertility
* Ovulation disorders (e.g., PCOS-related)
* Preconception care
* Egg quality improvement
* Hormonal imbalance
* Support during assisted reproduction (IVF/ICSI)
* General reproductive wellness
Dosage:
As directed by the physician.
Typical regimen:
* 1–2 capsules daily or as part of a structured fertility program
* Best taken consistently for at least 3 months for optimal effect
Contraindications:
* Hypersensitivity to any component
* Pregnancy and lactation (unless advised by physician)
* Severe metabolic or systemic disorders (consult physician)
Administration:
For oral use.
Take with water, preferably after meals.
Maintain regular daily intake for best results.
Interaction:
Generally well tolerated.
Use caution with:
* Antidiabetic medications (inositol may affect insulin sensitivity)
* Anticoagulants (Omega-3 may enhance effect)
* Thyroid medications (iodine content consideration)
Compatibility:
Compatible with most fertility treatment protocols.
Can be combined with hormonal therapy under medical supervision.
Stability / Storage:
Store below 25°C.
Protect from moisture, heat, and direct sunlight.
Keep out of reach of children.
Precautions:
* Not a substitute for a balanced diet
* Use under medical supervision in fertility treatment
* Monitor in patients with metabolic disorders (e.g., PCOS, diabetes)
* Avoid exceeding recommended dose
* Regular follow-up recommended during fertility treatment
Side Effects:
Generally well tolerated.
Possible mild effects:
* Gastrointestinal discomfort
* Nausea
* Bloating
Rare:
* Allergic reactions
* Headache
Website Note (Professional):
This product is a scientifically formulated fertility support supplement and should be used under the guidance of a healthcare professional, especially in patients undergoing fertility treatment.

WhatsApp-Image-2026-04-11-at-7.18.28-AM (52) (8) (1)

ANDROVIA-H® Capsules

ANDROVIA-H® Capsules
Generic Name:
L-Carnitine + Coenzyme Q10 + Zinc + Selenium + Vitamins + Antioxidants Complex
Therapeutic Group:
Urology / Andrology / Reproductive Health
Drug Category:
Male Fertility Nutraceutical (Advanced Antioxidant & Reproductive Support Formula)
Content / Composition:
Each capsule (or daily dose) contains a scientifically formulated blend of:
* L-Carnitine
* Coenzyme Q10 (CoQ10)
* Zinc
* Selenium
* Essential Vitamins (including Vitamin E, C, B-complex)
* Antioxidants & micronutrients supporting sperm health
Indications:
Indicated for male reproductive health and fertility enhancement, including:
* Male infertility
* Low sperm count (Oligospermia)
* Reduced sperm motility (Asthenospermia)
* Poor sperm quality and morphology
* Oxidative stress-related sperm damage
* Low testosterone-related symptoms (supportive)
* Preconception male fertility optimization
Dosage:
As directed by the physician.
Typical regimen:
* 1–2 capsules daily after meals
* Recommended duration: minimum 3 months (spermatogenesis cycle)
Contraindications:
* Hypersensitivity to any component
* Severe renal or hepatic impairment (consult physician)
* Not recommended for children
Administration:
For oral use.
Take with water after meals.
Maintain consistent daily intake for optimal results.
Interaction:
Use caution with:
* Anticoagulants (Vitamin E, Omega components if included)
* Antidiabetic medications
* Hormonal therapies
Compatibility:
Compatible with most fertility treatment protocols.
Can be combined with assisted reproductive techniques (IVF/ICSI) under supervision.
Stability / Storage:
Store below 25°C.
Protect from heat, moisture, and direct sunlight.
Keep out of reach of children.
Precautions:
* Not a substitute for medical infertility treatment
* Lifestyle modification (diet, smoking cessation) recommended
* Monitor in patients with metabolic disorders
* Avoid exceeding recommended dose
* Regular clinical follow-up advised
Side Effects:
Generally well tolerated.
Possible mild effects:
* Gastrointestinal discomfort
* Nausea
* Mild headache
Rare:
* Allergic reactions
Website Note (Professional):
This product is a scientifically developed male fertility support supplement.
Best results are achieved when used under medical guidance along with a comprehensive fertility plan.